These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 30793542)
1. AMH and INSL3 in testicular and extragonadal pathophysiology: what do we know? Sansone A; Kliesch S; Isidori AM; Schlatt S Andrology; 2019 Mar; 7(2):131-138. PubMed ID: 30793542 [TBL] [Abstract][Full Text] [Related]
2. Anti-Müllerian hormone, testosterone, and insulin-like peptide 3 as biomarkers of Sertoli and Leydig cell function during deslorelin-induced testicular downregulation in the dog. Balogh O; Somoskői B; Kollár E; Kowalewski MP; Gram A; Reichler IM; Klein R; Kawate N; Mester L; Walter B; Müller L Theriogenology; 2021 Nov; 175():100-110. PubMed ID: 34534687 [TBL] [Abstract][Full Text] [Related]
3. Male hypogonadism: an extended classification based on a developmental, endocrine physiology-based approach. Rey RA; Grinspon RP; Gottlieb S; Pasqualini T; Knoblovits P; Aszpis S; Pacenza N; Stewart Usher J; Bergadá I; Campo SM Andrology; 2013 Jan; 1(1):3-16. PubMed ID: 23258624 [TBL] [Abstract][Full Text] [Related]
4. Serum concentrations and testicular expressions of insulin-like peptide 3 and Anti-Müllerian hormone in normal and cryptorchid male horses. Tsogtgerel M; Komyo N; Murase H; Hannan MA; Watanabe K; Ohtaki T; Tsumagari S; Kawate N; Nambo Y Theriogenology; 2020 Sep; 154():135-142. PubMed ID: 32645589 [TBL] [Abstract][Full Text] [Related]
5. Serum levels of insulin-like factor 3, anti-Mullerian hormone, inhibin B, and testosterone during pubertal transition in healthy boys: a longitudinal pilot study. Johansen ML; Anand-Ivell R; Mouritsen A; Hagen CP; Mieritz MG; Søeborg T; Johannsen TH; Main KM; Andersson AM; Ivell R; Juul A Reproduction; 2014; 147(4):529-35. PubMed ID: 24459206 [TBL] [Abstract][Full Text] [Related]
6. Anti-Müllerian hormone, testicular descent and cryptorchidism. Rey RA; Grinspon RP Front Endocrinol (Lausanne); 2024; 15():1361032. PubMed ID: 38501100 [TBL] [Abstract][Full Text] [Related]
8. INSL3: A Marker of Leydig Cell Function and Testis-Bone-Skeletal Muscle Network. Facondo P; Delbarba A; Maffezzoni F; Cappelli C; Ferlin A Protein Pept Lett; 2020; 27(12):1246-1252. PubMed ID: 32981493 [TBL] [Abstract][Full Text] [Related]
9. INSL3 as a biomarker of Leydig cell functionality. Ivell R; Wade JD; Anand-Ivell R Biol Reprod; 2013 Jun; 88(6):147. PubMed ID: 23595905 [TBL] [Abstract][Full Text] [Related]
10. Testicular anti-mullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism. Young J; Chanson P; Salenave S; Noël M; Brailly S; O'Flaherty M; Schaison G; Rey R J Clin Endocrinol Metab; 2005 Feb; 90(2):724-8. PubMed ID: 15536161 [TBL] [Abstract][Full Text] [Related]
11. An Arato I; Luca G; Mancuso F; Bellucci C; Lilli C; Calvitti M; Hansen BC; Milardi D; Grande G; Calafiore R Asian J Androl; 2018; 20(2):160-165. PubMed ID: 29148520 [TBL] [Abstract][Full Text] [Related]
12. The prepubertal testis: biomarkers and functions. Valeri C; Schteingart HF; Rey RA Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):224-33. PubMed ID: 23549308 [TBL] [Abstract][Full Text] [Related]
13. Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression during postnatal testis development and in the adult testis of the rat. Baarends WM; Hoogerbrugge JW; Post M; Visser JA; De Rooij DG; Parvinen M; Themmen AP; Grootegoed JA Endocrinology; 1995 Dec; 136(12):5614-22. PubMed ID: 7588316 [TBL] [Abstract][Full Text] [Related]
14. Human testicular insulin-like factor 3: in relation to development, reproductive hormones and andrological disorders. Bay K; Andersson AM Int J Androl; 2011 Apr; 34(2):97-109. PubMed ID: 20550598 [TBL] [Abstract][Full Text] [Related]
15. Congenital hypogonadotropic hypogonadism and Kallmann syndrome as models for studying hormonal regulation of human testicular endocrine functions. Trabado S; Lamothe S; Maione L; Bouvattier C; Sarfati J; Brailly-Tabard S; Young J Ann Endocrinol (Paris); 2014 May; 75(2):79-87. PubMed ID: 24815726 [TBL] [Abstract][Full Text] [Related]
16. Hypogonadotropic hypogonadism as a model of post-natal testicular anti-Müllerian hormone secretion in humans. Young J; Rey R; Schaison G; Chanson P Mol Cell Endocrinol; 2003 Dec; 211(1-2):51-4. PubMed ID: 14656476 [TBL] [Abstract][Full Text] [Related]
17. Normal insulin-like peptide-3 levels despite low testosterone in adult males with Prader-Willi syndrome: variations in Leydig cell function from infancy through adulthood. Hirsch HJ; Eldar-Geva T; Gross-Tsur V; Benarroch F; Roger M; Lahlou N J Clin Endocrinol Metab; 2013 Jan; 98(1):E135-43. PubMed ID: 23150680 [TBL] [Abstract][Full Text] [Related]
18. Anti-müllerian hormone and sertoli cell function in paediatric male hypogonadism. Grinspon RP; Rey RA Horm Res Paediatr; 2010; 73(2):81-92. PubMed ID: 20190544 [TBL] [Abstract][Full Text] [Related]
19. Biomarkers of male hypogonadism in childhood and adolescence. Rey RA Adv Lab Med; 2020 Jun; 1(2):20200024. PubMed ID: 37363780 [TBL] [Abstract][Full Text] [Related]
20. Spreading the clinical window for diagnosing fetal-onset hypogonadism in boys. Grinspon RP; Loreti N; Braslavsky D; Valeri C; Schteingart H; Ballerini MG; Bedecarrás P; Ambao V; Gottlieb S; Ropelato MG; Bergadá I; Campo SM; Rey RA Front Endocrinol (Lausanne); 2014; 5():51. PubMed ID: 24847309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]